While RGS reduced viability in vitro in human and murine melanoma cells independent of their mutational status (Fig. 1), we observed that RGS exhibited little inhibition of tumor growth in immunodeficient mice (Fig. 6 & Suppl.Fig. 13). Here, PITX2 is linked to melanoma.